Terumo Corp. (OTCMKTS:TRUMY) Short Interest Down 91.6% in April

Terumo Corp. (OTCMKTS:TRUMY) was the target of a large decrease in short interest in April. As of April 30th, there was short interest totaling 30,823 shares, a decrease of 91.6% from the April 15th total of 367,048 shares. Approximately 0.0% of the company’s shares are short sold. Based on an average trading volume of 350,364 shares, the short-interest ratio is presently 0.1 days.

Terumo Stock Down 1.3%

OTCMKTS:TRUMY traded down $0.17 during midday trading on Monday, reaching $12.39. 471,423 shares of the stock traded hands, compared to its average volume of 209,291. Terumo has a 12-month low of $12.15 and a 12-month high of $20.12. The business has a 50-day moving average of $13.15 and a two-hundred day moving average of $14.17. The company has a debt-to-equity ratio of 0.07, a quick ratio of 0.89 and a current ratio of 1.51. The stock has a market capitalization of $18.28 billion, a PE ratio of 21.66 and a beta of 0.62.

Terumo (OTCMKTS:TRUMY) last posted its earnings results on Friday, February 13th. The company reported $0.14 EPS for the quarter, missing analysts’ consensus estimates of $0.15 by ($0.01). The firm had revenue of $1.94 billion for the quarter, compared to analysts’ expectations of $1.82 billion. Terumo had a net margin of 11.74% and a return on equity of 9.01%. On average, equities analysts forecast that Terumo will post 0.58 earnings per share for the current fiscal year.

Analyst Ratings Changes

TRUMY has been the topic of a number of research analyst reports. Nomura upgraded shares of Terumo to a “hold” rating in a research note on Tuesday, February 24th. Zacks Research raised shares of Terumo to a “hold” rating in a research report on Thursday, April 9th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold”.

About Terumo

Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.

Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.